Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Intelliguard and Codonics Partner to Strengthen Patient Safety

    Dec 9, 2024, 08:06 AM by
    Intelliguard, a provider of medication management and data-intelligence solutions, announces a strategic partnership with Codonics, a global leader in healthcare technology offering cutting-edge solutions for patient safety. This partnership allows Intelliguard’s Mira Care Station customers to leverage the Codonics Safe Label System (SLS) for fast, compliant, and standardized syringe labeling, ensuring a closed-loop medication process in operating rooms.
    Full story
  • CB Insights Recognizes Proscia Among Most Promising Digital Health Companies Of 2024

    Dec 6, 2024, 07:12 AM by
    Proscia also ranks as the top vendor in diagnostic digital pathology market landscapes.
    Full story
  • New digital health fund KELES appoints three expert advisors to accelerate healthcare growth across Europe

    Dec 5, 2024, 07:35 AM by
    KELES, venture capital firm led by digital health investors David Buller and Laurent Van Lerberghe, appoints three expert advisors to strengthen its leadership team and accelerate progress in European digital health innovation.
    Full story
  • ‘Therapeutic EVs’ in a Nasal Spray Could One Day Treat Alzheimer’s Disease

    Dec 5, 2024, 01:00 AM by User Not Found
    Bio-IT World | It sounds too good to be true: a nasal spray that delays Alzheimer’s-related behavioral and cognitive problems a decade or more after initial diagnosis. But promising first steps in that direction have already been taken using “therapeutic EVs” (extracellular vesicles) restricting the activation of inflammatory cytokines in the brain of mice.
    Full story
  • Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser, Amperia, to market

    Dec 4, 2024, 08:26 AM by
    Abselion has secured £6.6 million in Series A financing to bring its award-winning Amperia system to market.
    Full story
  • Cotiviti Welcomes Seasoned Technology Executive Suvajit Gupta as Chief Technology Officer

    Dec 4, 2024, 08:26 AM by
    Full story
  • Building Tiny Biocompatible Batteries with Heart-Defibrillating Power

    Dec 4, 2024, 01:00 AM by User Not Found
    Bio-IT World | In a paper published last week in Science, researchers from the University of Oxford, UK, demonstrate how microprocessors can be created from soft, biocompatible, nanoliter-scale hydrogel droplets. This work builds on a study published last month in Nature Chemical Engineering introducing poppyseed-sized droplet batteries that can be used to power such systems for various bionic and biomedical applications.
    Full story
  • Biocair strengthens its customer focus in 2024 and prepares for another year of growth

    Dec 3, 2024, 07:41 AM by
    Full story
  • Duke Street Bio Announces First Patient Dosed in Phase I Trial with DSB2455, a Next Generation PARP1 Selective Inhibitor for the Treatment of Solid Tumours

    Dec 3, 2024, 07:41 AM by
    Duke Street Bio Ltd has announced that the first patient has been dosed with its highly selective PARP1 inhibitor, DSB2455, in a Phase 1 clinical trial after European Medicines Agency approval earlier this year.
    Full story
  • Barcelona Research Institutions Launch Joint Program on Evolutionary Medical Genomics

    Dec 3, 2024, 01:00 AM by User Not Found
    Bio-IT World | Three research institutions in Barcelona have teamed up to launch the world’s first Joint Program on Evolutionary Medical Genomics. The initiative, launched last month at an inaugural symposium in Barcelona Biomedical Research Park (PRBB), is a collaboration between the Centre for Genomic Regulation (CRG), the Department of Medicine and Life Sciences at the Universitat Pompeu Fabra (UPF), and the Institut de Biologia Evolutiva
    Full story
  • Clinion Wins 2024 SCDM Innovation Award for Excellence in Clinical Data Science

    Dec 2, 2024, 08:16 AM by
    Clinion’s groundbreaking platform is revolutionizing clinical trials, demonstrating how cutting-edge technology is expediting the journey of new therapies to market.
    Full story
  • Capricor Therapeutics Showcases Groundbreaking Exosome Therapy Platform at 2024 AAEV Annual Meeting

    Dec 2, 2024, 08:16 AM by
    Capricor Therapeutics announced that it would introduce the abstract about the pre-clinical data, giving a spotlight on the therapeutic potential of its StealthX exosome platform technology at the 2024 American Association of Extracellular Vesicles Annual Meeting in Texas.
    Full story
  • India Charts BioE3 Policy to Propel Advanced Biomanufacturing

    Nov 27, 2024, 09:10 AM by
    The government announced the BioE3 (Biotechnology for Economy, Environment and Employment) policy, a strategic plan to take India to the next era of industrialization through advanced biomanufacturing. Enhancing India’s biomanufacturing capabilities by integrating science, technology, engineering, and manufacturing will enable institutions, universities, startups, and industries in India to participate in innovation, thereby supporting the growth of the upstream bioprocessing market.
    Full story
  • Tillotts Pharma partners with Pioneer for the marketing and distribution of Tillotts` product Asacol® in the People’s Republic of China

    Nov 27, 2024, 09:10 AM by
    Tillotts Pharma AG and Pioneer Pharma (Hong Kong) Co., Limited has announced the signing of an exclusive agreement covering the distribution and marketing of Tillotts’ product Asacol® Tablets 800mg in the mainland of the People’s Republic of China.
    Full story
  • Hovione Expands Global Spray Drying Capacity with Significant Investment in the USA and Ireland

    Nov 26, 2024, 08:28 AM by
    Full story
  • AKASA Named Among Fastest Growing Generative AI Startups to Watch

    Nov 26, 2024, 08:28 AM by
    Full story
  • Follow the Money: Seaport Therapeutics Glyph Platform, Pathos AI Expansion, More

    Nov 26, 2024, 01:00 AM by User Not Found
    Bio-IT World | Seaport nets funds for its Glyph technology platform; Pathos AI plans to accelerate its AI-powered drug development platform; Alentis Therapeutics pursues antibody drug conjugates; and more.
    Full story
  • Biopharma PEG Offers 30% Thanksgiving Discount on Monodispersed PEGs

    Nov 25, 2024, 08:27 AM by
    Biopharma PEG Scientific Inc. is offering a 30% Thanksgiving discount on select monodispersed PEGs, including mPEG36-NH2, N3-PEG6-OH, and N3-PEG11-NH2. These high-purity, GMP-grade products are ideal for applications like PEGylation, ADC linkers, and PROTAC linkers. The offer is valid until December 4, 2024, at 23:59 EST. Contact us to take advantage of this limited-time promotion.
    Full story
  • Phreesia Named to The Software Report’s “Top 100 Software Companies” for the Third Consecutive Year

    Nov 25, 2024, 08:27 AM by
    Phreesia has been selected by The Software Report as one of the “Top 100 Software Companies of 2024” for a third consecutive year.
    Full story
  • Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

    Nov 25, 2024, 01:00 AM by User Not Found
    Bio-IT World | Answer ALS and Cedars-Sinai have announced the completed availability of the largest ALS patient-based induced pluripotent stem cell and bio data repository; Scale Biosciences and Revvity’s business, BioLegend, announced the availability of a first-of-its-kind TotalSeq Phenocyte single-cell protein profiling solution that supports customers by more easily identifying and characterizing rare cell subtypes; ChapsVision has acquired Sinequa; and more.
    Full story
  • «
  • 11
  • 12 (current)
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy